Prostate Cancer
TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)
- Details
ClinicalTrials.gov ID:
NCT02975934
Diagnosis Type:
NA
USOR Number:
- Address
3705 West 15th Street
Plano, TX 75075
P: (972) 867-3577